Pelvic lymph node dissection is beneficial in subsets of patients with node-positive melanoma

Annals of Surgical Oncology

Volumn 14, Issue 10, 2007, Pages 2867-2875

  Badgwell, Brian ^a   Xing, Yan ^a   Gershenwald, Jeffrey E ^a   Lee, Jeffrey E ^a   Mansfield, Paul F ^a   Ross, Merrick I ^a   Cormier, Janice N ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Iliac and obturator nodes; Melanoma; Pelvic lymph nodes

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LOGISTIC REGRESSION ANALYSIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MELANOMA; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PELVIS LYMPH NODE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; SURVIVAL TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PELVIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

EID: 34648825823     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9512-7     Document Type: Article

References (29)

1. The NCCN GUIDELINE: Clinical Practice Guidelines in Oncology (Version 3.2005). © 2006 National Comprehensive Cancer Network, Inc. Available at: http://www.nccn.org. Accessed [March 6, 2007]
2. Kubik S. Textbook of Lymphology. 1st edn. Elsevier GmbH, Munchen, 2003
3. Kretschmer L, Neumann C, Preusser KP, Marsch WC. Superficial inguinal and radical ilioinguinal lymph node dissection in patients with palpable melanoma metastases to the groin-an analysis of survival and local recurrence. Acta Oncol 2001; 40(1):72-78
4. Hughes TM, A'Hern RP, Thomas JM. Prognosis and surgical management of patients with palpable inguinal lymph node metastases from melanoma. Br J Surg 2000; 87(7):892-901
5. Mann GB, Coit DG. Does the extent of operation influence the prognosis in patients with melanoma metastatic to inguinal nodes? Ann Surg Oncol 1999; 6(3):263-271
6. Meyer T, Merkel S, Gohl J, Hohenberger W. Lymph node dissection for clinically evident lymph node metastases of malignant melanoma. Eur J Surg Oncol 2002; 28(4):424-430
7. Strobbe LJ, Jonk A, Hart AA, et al. Positive iliac and obturator nodes in melanoma: survival and prognostic factors. Ann Surg Oncol 1999; 6(3):255-262
8. Essner R, Scheri R, Kavanagh M, et al. Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection. Arch Surg 2006; 141(9):877-882
9. Karakousis CP, Driscoll DL, Rose B, Walsh DL. Groin dissection in malignant melanoma. Ann Surg Oncol 1994; 1(4):271-277
10. Coit DG, Brennan MF. Extent of lymph node dissection in melanoma of the trunk or lower extremity. Arch Surg 1989; 124(2):162-166
11. McCarthy JG, Haagensen CD, Herter FP. The role of groin dissection in the management of melanoma of the lower extremity. Ann Surg 1974; 179(2):156-159
12. Jonk A, Kroon BB, Rumke P, et al. Results of radical dissection of the groin in patients with stage II melanoma and histologically proved metastases of the iliac or obturator lymph nodes, or both. Surg Gynecol Obstet 1988; 167(1):28-32
13. Karakousis CP, Driscoll DL. Positive deep nodes in the groin and survival in malignant melanoma. Am J Surg 1996; 171(4):421-422
14. Ballo MT, Zagars GK, Gershenwald JE, et al. A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma. Ann Surg Oncol 2004; 11(12):1079-1084
15. Greene FL, American Joint Committee on Cancer, American Cancer Society. Chapter 24 Melanoma of the Skin. AJCC cancer staging handbook: from the AJCC cancer staging manual. Springer, New York, 2002: pp. 239
16. Kaplan EL. Nonparametric estimator from incomplete observations. J Am Stat Assoc 1958; 53:457-481
17. Cox DR. Regression models and life tables. J.R. Stat Soc 1972; B34:187-220
18. Therneau T.M, Grambsch PM. Modeling Survival Data: Extending the Cox Model. Springer, New York, 2000
19. Karakousis CP, Driscoll DL. Groin dissection in malignant melanoma. Br J Surg 1994; 81(12):1771-1774
20. Finck SJ, Giuliano AE, Mann BD, Morton DL. Results of ilioinguinal dissection for stage II melanoma. Ann Surg 1982; 196(2):180-186
21. Balch CM, Soong S-J, Atkins MB, et al. An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin 2004; 54(3):131-149
22. Buzaid AC, Ross MI, Balch CM, et al. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J Clin Oncol 1997; 15(3):1039-1051
23. Buzaid AC, Tinoco LA, Jendiroba D, et al. Prognostic value of size of lymph node metastases in patients with cutaneous melanoma. J Clin Oncol 1995; 13(9):2361-2368
24. Balch CM, Buzaid AC, Soong S-J, et al. Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol 2001; 19(16):3635-3648
25. Balch CM, Soong S-J, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer Melanoma Staging System. J Clin Oncol 2001; 19(16):3622-3634
26. Balch CM, Soong S, Ross MI, et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol 2000; 7(2):87-97
27. Cascinelli N, Belli F, Santinami M, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 2000; 7(6):469-474
28. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999; 17(3):976-983
29. Gershenwald JE, Berman RS, Porter G, et al. Regional nodal basin control is not compromised by previous sentinel lymph node biopsy in patients with melanoma. Ann Surg Oncol 2000; 7(3):226-231